South Korea

Noul Co. Ltd's The RIGHT Foundation Begins Research and Development to Aid Malaria Control

Noul Co. Ltd (CEO : David Lim) announced that it has signed an agreement with The RIGHT Foundation to conduct a global clinical studies to determine t...

 March 28, 2023 | News

Phase 1 trial of OLX72021of Treatment of Androgenic Alopecia has been approved for initiation in Australia

OliX will evaluate the safety and tolerability of OLX72021 in Phase 1 clinical trial Excellent hair growth effect is observed when used as external solu...

 March 27, 2023 | News

Daewoong Pharma's Envlo files for product license in three ASEAN countries to enter global market

Submitted an NDA to Indonesia, Philippines and Thailand Signed the export contract in Brazil and Mexico in last ...

 March 23, 2023 | News

Lunit Meets MDR CE Requirements for 3D Breast Tomosynthesis AI Solution

Lunit set to launch Lunit INSIGHT DBT in the European market Lunit seeks FDA clearance, paving the way into the US market The MDR CE certification is...

 March 21, 2023 | News

Samsung Biologics to build Plant 5 for Bio Campus II expansion.

The company plans to begin construction in the first half of 2023 and commence operations in 2025 As part of Samsung Biologics' second Bio Campus, ...

 March 17, 2023 | News

Medit Launches New Occlusion Analyzer App for Quick and Easy Analysis

The Medit Occlusion Analyzer is a powerful tool that allows dental professionals to perform occlusion analysis quickly and easily without the need to ret...

 March 09, 2023 | News

ExoCoBio Obtains GMP Licenses for Exosome Biopharmaceuticals and HA Dermal Fillers

ExoGMP™ is the world's largest exosome manufacturing facility in Osong, South Korea. Cellosome™ HA fillers are expected to be approved ...

 March 02, 2023 | News

GC Biopharma Acquires Catalyst Biosciences' Rare Disease Pipeline in Hematology

GC Biopharma Corp. (006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that it has signed an Asset Purchase ...

 February 28, 2023 | News

Microbiome Connect: Asia – A Must-Attend Event for Advancing Microbiome Research and Development in Asia Pacific

Download the Agenda : Microbiome Connect is proud to announce the launch of Microbiome Connect: Asia, the premier con...

 February 28, 2023 | News

SK bioscience’s Shingles Vaccine Secures the Highest Market Share in South Korea

‘SKYZoster®, ' the world second developed shingles vaccine secures 54% of the South Korean market share  With proven immunogenicity and s...

 February 28, 2023 | News

Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd

Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, has agreed to acquire Taew...

 February 24, 2023 | News

Rayence unveils the first X-ray detector technology utilizing SPAD technology

  Presenting the cutting-edge detector technology, 'SPAD-GS', which is 2.5 times more sensitive to X-rays and 4 times faster than ever Implemented...

 February 24, 2023 | News

Altos Biologics Enrolls Patients in Global Phase 3 Trial for Eylea® Biosimilar in Neovascular Age-related Macular Degeneration.

  Altos Biologics, a subsidiary of Alteogen, is actively engaged in Eylea® Biosimilar (ALT-L9) clinical development and licensing-out disc...

 February 23, 2023 | News

Celltrion and LISCure Biosciences to develop novel microbiome treatment for Parkinson's disease

Co-research and co-development of novel microbiome therapeutics Discovery of new candidates to meet high unmet medical needs in Parkinson's disease U...

 February 21, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in